While its expression is typically low in healthy individuals, there is a significant increase in GFAP expression and concentrations observed in the brains of patients with AD, especially in regions surrounding Aβ plaques, and increased with the accumulation of tau in the brains64,66. The gene discussed is MAPT; the disease is Alzheimer disease.